Immunophotonics Overview

  • Year Founded
  • 2012

Year Founded

  • Status
  • Private

  • Employees
  • 12

Employees

  • Latest Deal Type
  • PE Growth

  • Financing Rounds
  • 13

Immunophotonics General Information

Description

Developer of a proprietary carbohydrate polymer designed to transform tumor ablation into hypnotherapy for cancer. The company's compound is intratumorally injected after tumor ablation, utilizing the full repertoire of tumor-associated neoantigens available in situ for the immune system after ablation-based immunogenic cell death, inducing a systemic anti-tumor immune response, enabling clinicians to treat late-stage metastatic cancers.

Contact Information

Website
www.immunophotonics.com
Ownership Status
Privately Held (backing)
Financing Status
Private Equity-Backed
Corporate Office
  • 4340 Duncan Avenue, BioGenerator Labs
  • Suite 212
  • Saint Louis, MO 63110
  • United States
+1 (314)
Primary Industry
Drug Discovery
Other Industries
Biotechnology
Vertical(s)
HealthTech, Life Sciences, Oncology
Corporate Office
  • 4340 Duncan Avenue, BioGenerator Labs
  • Suite 212
  • Saint Louis, MO 63110
  • United States
+1 (314)

Immunophotonics Timeline

2023202420252026
Financing RoundCaptured Employee CountEstimated Employee Growth

Want detailed data on 11M+ companies?

What you see here scratches the surface

Request a free trial

Want to dig into this profile?

We’ll help you find what you need

Learn more

Immunophotonics Valuation & Funding

Deal Type Date Amount Valuation/
EBITDA		 Post-Val Status Debt

This information is available in the PitchBook Platform. To explore Immunophotonics‘s full profile, request access.

Request a free trial

Immunophotonics Comparisons

Description
Primary
Industry
HQ Location
Employees
Total Raised
Post Valuation
Last
Financing
Details
Developer of a proprietary carbohydrate polymer designed to transform tumor ablation into hypnotherapy for cancer. The c
Drug Discovery
Saint Louis, MO
12 As of 2026

Waltham, MA
 

Santa Monica, CA
 
Add Comparison

PitchBook’s comparison feature gives you a side-by-side look at key metrics for similar companies. Personalize which data points you want to see and create visualizations instantly.

Request a free trial

Immunophotonics Competitors (59)

One of Immunophotonics’s 59 competitors is Cogent Biosciences, a Formerly VC-backed company based in Waltham, MA.

Company Name Financing Status Location Employees Total Raised Last Financing Date/Type Last Financing Amount
Cogent Biosciences Formerly VC-backed Waltham, MA
Kite Pharma Formerly VC-backed Santa Monica, CA
Oncorus Formerly VC-backed Andover, MA
Gracell Formerly VC-backed Shanghai, China
Meditope Biosciences Formerly VC-backed Pasadena, CA
You’re viewing 5 of 59 competitors. Get the full list »

Immunophotonics Patents

  • 45

    Total Documents Applications and Grants

  • Total Patents Families

  • 21

    Granted

  • 12

    Pending

  • Expiring in next 12 mo

Immunophotonics Recent Patent Activity

Publication ID Patent Title Status First Filing Date Technology (CPC) Citations
WO-2026128424-A1 Compositions of chitosan and modified chitosans Pending 10-Dec-2024
CA-3232497-A1 Methods for producing glycated chitosans Pending 21-Sep-2021
EP-4405399-A1 Methods for producing glycated chitosans Pending 21-Sep-2021
EP-4405399-A4 Methods for producing glycated chitosans Pending 21-Sep-2021
US-20250122313-A1 Methods for producing glycated chitosans Pending 21-Sep-2021 C08B37/003
To view Immunophotonics’s complete patent history, request access »

Immunophotonics Signals

Growth Rate

Weekly
Growth
Weekly Growth

Size Multiple

Median
Size Multiple

Key Data Points

Similarweb Unique Visitors

Majestic Referring Domains

PitchBook’s non-financial metrics help you gauge a company’s traction and growth using web presence and social reach.

Request a free trial

Immunophotonics Investors

Investor Name Investor Type Holding Investor Since Participating Rounds Contact Info

This information is available in the PitchBook Platform. To explore Immunophotonics‘s full profile, request access.

Request a free trial

Immunophotonics FAQs

  • When was Immunophotonics founded?

    Immunophotonics was founded in 2012.

  • Where is Immunophotonics headquartered?

    Immunophotonics is headquartered in Saint Louis, MO.

  • What is the size of Immunophotonics?

    Immunophotonics has 12 total employees.

  • What industry is Immunophotonics in?

    Immunophotonics’s primary industry is Drug Discovery.

  • Is Immunophotonics a private or public company?

    Immunophotonics is a Private company.

  • What is Immunophotonics’s current revenue?

    The current revenue for Immunophotonics is .

  • How much funding has Immunophotonics raised over time?

    Immunophotonics has raised $104M.

  • Who are Immunophotonics’s investors?

    Horizen Capital, , ROVAQ Ventures, SeedFolio, and Zubizoom Investments are 5 of 11 investors who have invested in Immunophotonics.

  • Who are Immunophotonics’s competitors?

    Cogent Biosciences, Kite Pharma, Oncorus, Gracell, and Meditope Biosciences are some of the 59 competitors of Immunophotonics.

Data Transparency

  • Meet our data hygiene team

    Discover how our experts ensure you’re getting the most accurate financial data in the industry.

    Read more

  • How PitchBook sources data

    Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.

    Discover our process